Currently there are no treatments for Advanced Dry AMD, also known as GA, which can lead to significant central vision loss.The National Eye Institute (NEI), one of the federally funded National Institutes of Health, is launching the first clinical trial in the US for induced pluripotent stem cells (iPSC), stem cells that are derived from mature human cells. The iPSC in the landmark study are being derived from the patient’s own blood and developed into retinal pigment epithelial (RPE) cells for the treatment of geographic atrophy (GA), the advanced form of dry age-related macular degeneration (AMD), which causes progressive central...